Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas

BACKGROUND: Several studies have suggested that anti-silencing function 1 B (ASF1B) can serve as a good potential marker for predicting tumor prognosis. But the values of ASF1B in gliomas have not been elucidated and further confirmation is needed. METHODS: Transcriptomic and clinical data were down...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Huaxin, Ouyang, Hengyang, Pan, Xinyi, Zhang, Zhixiong, Tan, Jiacong, Yu, Nianzu, Li, Meihua, Zhao, Yeyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298524/
https://www.ncbi.nlm.nih.gov/pubmed/35875094
http://dx.doi.org/10.3389/fonc.2022.912101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298524/
https://www.ncbi.nlm.nih.gov/pubmed/35875094
http://dx.doi.org/10.3389/fonc.2022.912101

Ejemplares similares